WALDENSTROM MACROGLOBULINEMIA
Clinical trials for WALDENSTROM MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTROM MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for WALDENSTROM MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New strategy aims to tame common virus threat after stem cell transplants
Disease control OngoingThis study looks at a modified approach to prevent and treat cytomegalovirus (CMV) infection in people who have had a donor stem cell transplant for blood cancers or related disorders. About 153 participants will be monitored to see if delaying or adjusting anti-CMV therapy can s…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New transplant combo aims to tame Graft-Versus-Host disease
Disease control OngoingThis study tests a stem cell transplant method for people with blood cancers like leukemia or lymphoma. The approach combines chemotherapy and radiation before transplant with a drug called cyclophosphamide after transplant to lower the risk of graft-versus-host disease, where do…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis study tests an experimental drug called nemtabrutinib (ARQ 531) in about 190 adults with certain blood cancers (like lymphoma or leukemia) that returned or didn't respond to prior therapy. The goal is to check the drug's safety and how well it works. Participants take the dr…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE1, PHASE2 • Sponsor: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis early-stage study tests an experimental pill called LOXO-338 in people with advanced blood cancers (like leukemia, lymphoma, or multiple myeloma) who have already tried standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors or impro…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New combo therapy aims to calm nerve pain in rare blood conditions
Disease control OngoingThis study tests whether combining acalabrutinib with rituximab (a standard antibody treatment) is safe and effective for people with nerve damage linked to two blood disorders: IgM MGUS and Waldenstrom macroglobulinemia. The goal is to reduce abnormal IgM protein levels, which c…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
Scientists hunt for hidden genes behind family blood cancers
Knowledge-focused OngoingThis study looks at people and families who may have a higher chance of getting blood or lymph node cancers, like leukemia or lymphoma. Researchers want to learn what causes these cancers by studying genes, environment, and medical history. Participants fill out questionnaires, g…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:03 UTC